Healios KK 4593
TSE · Japan · Health Technology
¥287.00-6.00 (-2.05%)
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · JPY · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
As inflation pressures rise amid higher energy costs, major Asian markets have shown mixed performance with investor sentiment being influenced by geopolitical uncertainties and economic indicators. In this environment, identifying high growth tech stocks in Asia requires a focus on companies that demonstrate resilience and adaptability to shifting market dynamics while capitalizing on emerging technological trends.
NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the Jefferies Global Healthcare Conference in New York City as follows: Date: Thursday, June 4, 2026Time: 7:35AM EDTWebcast: Click Here To schedule a 1x1 meeting with Healios, please contact your Jefferies representative at [email protected]. The live and archived webcast will be accessible from the Healios website. The replay
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.